Lysosomes play an essential role in cellular protein catabolism, participating in both the degradation of extracellular proteins that are transported through enodocytic-phagocytic pathways and the turnover of intracellular constituents via autophagy, a process with unique membrane dynamics. Among the lysosomal proteinases, which comprise a diverse group of enzymes, the cysteine proteinases, including cathepsin B and cathepsin L, make a significant contribution to non-specific lysosomal proteolysis. Target deletion of cathepsins B and L in mice has shed light on the specific role that each cathepsin plays in intracellular protein degradation.
Lysosomes play an essential role in cellular protein catabolism, participating in both the degradation of extracellular proteins that are transported through enodocytic-phagocytic pathways and the turnover of intracellular constituents via autophagy, a process with unique membrane dynamics. Among the lysosomal proteinases, which comprise a diverse group of enzymes, the cysteine proteinases, including cathepsin B and cathepsin L, make a significant contribution to non-specific lysosomal proteolysis. Target deletion of cathepsins B and L in mice has shed light on the specific role that each cathepsin plays in intracellular protein degradation. 1, 2) However, standard laboratory manipulation of cultured cell systems is needed further to clarify the different functions of each cathepsin. While seeking a type-specific inhibitor of cathepsin, our group previously synthesized a cathepsin B-specific inhibitor, N-(L-3-trans-(propylcarbamoyl)-oxilane-2-carbonyl)-L-isoluecyl-L-proline (CA-074). This inhibitor has been widely used in the identification of specific roles for cathepsin B in lyosomal proteolysis, antigen processing, viral infection, and so on. [3] [4] [5] [6] [7] During the course of this earlier study, in addition to CA-074, Ͼ30 compounds were newly synthesized; however, since they did not specifically inhibit cathepsin B activity they were not further investigated. Some of these compounds have an N-(trans-carbamoyloxylane-2-carbonyl)-L-phenylalanine moiety, as does CLIK148, which is a specific inhibitor of cathepsin L. 8, 9) Because of this common structural feature, we decided to re-examine these compounds to determine whether they specifically inhibit cathepsin L. One of the compounds tested, CAA0225 ((2S, 3S)-Oxirane-2,3-dicarboxylic acid 2-[((S)-1-benzylcarbamoyl-2-phenyl-ethyl)-amide] 3-{[2-(4-hydroxy-phenyl)-ethyl]-amide}), strongly inhibited purified rat liver cathepsin L but had little effect on rat liver cathepsin B. Therefore we set out to characterize this compound as a specific inhibitor of cathepsin L. In the present study, the compound was used to clarify unique contributions of cathepsin L and cathepsin B to autophagic proteolysis.
Autophagy is a cellular catabolic process responsible for the turnover of cell organelles including mitochondria, endoplasmic reticulum, and peroxisomes, as well as cytosolic proteins. [10] [11] [12] [13] Autophagy is enhanced during starvation due to the presence of catabolic hormones such as glucagon. Upon nutrient deprivation, a unique double-membrane structure, which is called an isolation membrane, forms and non-selectively surrounds a portion of the cytoplasm. The two edges of the expanding isolation membrane seal to form an autophagosome with cytoplasmic components sequestered in the lumen. The autophagosome then fuses with a lysosome to mature into a single-membrane autolysosome, in which sequestered cytoplasmic components are degraded by lysosomal proteinases. It should be noted that the inner autophagosomal membranes are also degraded after fusion of autophagosomes and lysosomes. 14, 15) An unequivocal marker of autophagosomal membranes is phosphatidylethanolamineconjugated microtubule-associated protein IA/IB light chain 3 (LC3). 16, 17) LC3 is synthesized as a soluble precursor form (proLC3), which is cleaved by Atg4B, a cysteine proteinase, to expose the carboxyl-terminal glycine. The processed form, LC3-I, is subsequently conjugated with phosphatidylethanolamine to form LC3-II, which has the characteristics of an integral membrane protein that is then recruited onto autophagosomal membranes. The cellular level of LC3-II increases upon autophagosome formation and decreases upon autophagosomal maturation into autolysosomes. 16, 18, 19) In the presence of (L-3-trans-ethoxycarbonyloxirane-2-carbonyl)-L-leucine (3-methylbutyl)amide (E64d) and pepstatin A, which are inhibitors of lysosomal cysteine proteinases and cathepsin D, respectively, autolysosomal degradation of LC3-II is effectively inhibited and LC3-II accumulates. 18, 20) Therefore ongoing autophagy activity can be assessed by quantifying cellular levels of LC3-II with and without inhibitors using immunofluorescence and immunoblotting. [19] [20] [21] In the present study, we used cathepsin-specific inhibitors to compare the relative contributions of cathepsin L and cathepsin B to both autophagic proteolysis of sequestered cytoplasimic proteins and autolysosomal degradation of LC3-II.
MATERIALS AND METHODS

Reagents
All reagents used were of analytical grade and purchased from the following sources: Phe-Arg-methylcoumarylamide (MCA), Arg-Arg-methylcoumarylamide (MCA), MOCAc-Gly-Lys-Pro-ILe-Leu-Phe-Phe-Arg-Leu- Animals Male Wistar rats were maintained in an environmentally controlled room (lights on 6:00-20:00) for Ն2 weeks before use in the experiments. All rats were fed a standard pelleted laboratory chow and allowed tap water ad libitum during this period. All animal experiments were approved by the Review Board of the Center for Biomedical Research Resources of Juntendo University.
Antibodies Anti-actin antibody was purchased from Sigma-Aldrich Corporation (Tokyo, Japan). The horseradish peroxidase conjugate of anti-rabbit IgG (heavy and light chainspecific) was obtained from Jackson ImmunoResearch Laboratories, Inc. (West Grove, PA, U.S.A.). Anti-LC3 and anti-gaminobutyric acid receptor A associated protein (GABARAP) antibodies were produced in rabbits according to previously published procedures. 18, 22, 23) Synthesis of CAA0225 CAA0225 is one of the derivatives of E64c that were previously synthesized at the Research Center, Taisho Pharmaceutical Co. as previously described by Murata et al.
3) All these derivatives were characterized by IR, proton NMR, and fast atom bombardment MS. The purity of these compounds was ascertained by thin-layer chromatography. Analytical Methods Protein was determined using the BCA protein assay kit according to the manufacturer's protocol. Cathepsin L and cathepsin B were isolated from Wistar rats and purified as described previously. 24, 25) The activities of cathepsins BϩL and cathepsin B were determined using the fluorogenic substrates z-Phe-Arg-MCA and z-Arg-Arg-MCA, respectively, as previously described. 26) Cathepsin D activity was determined as described previously using the fluorogenic substrate, MOCAc-Gly-Lys-Pro-ILe-Leu-PhePhe-Arg-Leu-Lys-(Dnp)-NH 2 .
27) Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) was performed using a published procedure. 28) Immunoblot analyses were performed as described previously 29) using either SuperSignal West Pico Chemiluminescent Substrate or SuperSignal West Dura Extended Duration Substrate (Pierce) as the substrate for the horseradish peroxidase conjugate of the secondary antibodies.
Cell Culture Huh-7 and HeLa cells were cultured and maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum (DMEM/10% FCS). Autophagic protein degradation was induced as follows. Cells grown in 6-cm dishes were washed with 20 mM Na-phosphate (pH 7.5)-0.15 M NaCl (PBS) and supplemented with Hank's balanced salt solution containing 10 mM HepesNaOH (pH 7.4) (HBSS-Hepes). The cells were incubated at 37°C for 4 h in the presence or absence of 10 mg/ml E64d, CA-074-Me, or CAA0225. The cells were removed from dishes using cell scrapers and centrifuged at 800 rpm for 5 min. The pelleted cells were suspended in PBS containing proteinase inhibitors (Nakarai Tesque) and lysed by sonication at 0°C for 10 s. The cell lysates were mixed with SDS-PAGE sample buffer, incubated at 100°C in a water bath, and subjected to immunoblotting analyses.
Protein Degradation Assay Huh-7 and HeLa cells grown in 24-well microplates were incubated with DMEM/ 10% FCS containing [ 14 C]-leucine (0.5 mCi/ml) for 22 h to label long-lived proteins. The cells were then washed with DMEM/10% FCS containing 2 mM unlabelled leucine and incubated with the medium for 2 h to allow degradation of short-lived proteins and to minimize re-incorporation of labeled leucine released by proteolysis. The cells were then washed with 20 mM Na-phosphate (pH 7.4) and 0.15 M NaCl (PBS), and incubated at 37°C with either HBSS-Hepes or DMEM/10% FCS in the presence or absence of protease inhibitors. During the next 3 h of the chase period, aliquots of the medium were removed and a one-tenth volume of 100% trichloroacetic acid was added to each aliquot. The mixtures were centrifuged at 12000ϫg for 5 min, and acid-soluble radioactivity was determined by liquid scintillation counting. At the end of the experiment, the cultures were washed with PBS, and 1 ml of cold trichloroacetic acid was added to fix the cellular proteins. The fixed-cell monolayers were washed with trichloroacetic acid and dissolved in 0.5 ml of 1 N NaOH at 37°C. The amount of radioactivity in each aliquot of 1 N NaOH was determined by liquid scintillation counting. Percent protein degradation was calculated using a previously published procedure. 30) Preparation of Mitochondrial/Lysosomal (ML) Frac-tion from Mouse Livers Livers Isolated from C57/B6J mice were dissected into small pieces with scissors and suspended into five volumes of 5 mM Tes-NaOH (pH 7.4) containing 0.3 M sucrose. The suspension was homogenized with a motor-driven glass/Teflon homogenizer (5 up-down strokes at 800 rpm). The homogenate was centrifuged at 500ϫg for 5 min and the supernatant further centrifuged at 10000ϫg for 20 min. The pellets (ML fraction) were suspended in 5 mM Tes-NaOH (pH 7.4) containing 0.3 M sucrose.
Data Analysis Results are presented as meanϮS.D. Statistical difference between two groups was calculated by Student's t-test. A p-value Ͻ0.05 denoted the presence of statistically significant difference.
RESULTS
Previously, our group developed a novel cathepsin B-specific inhibitor, CA-074. [3] [4] [5] [6] While developing the inhibitor, we noticed that the L-trans-epoxy-succinic acid group was important for specific interaction with cathepsin B; therefore we designed Ͼ30 different compounds that have this moiety in common. However, except for CA-074, these compounds did not specifically inhibit purified cathepsin B. At that time, we did not examine these compounds further. However, we hypothesized that some of these compounds might be cathepsin L-specific inhibitors, despite their lack of specificity for cathepsin B. We therefore systematically reexamined the effects of these compounds on cathepsin L and cathepsin B purified from rat liver. Table 1 shows that one of the compounds, CAA0225, strongly inhibited cathepsin L with IC 50 values ranging at 2-10 nM; however, inhibition of cathepsin B was negligible (IC 50 values, Ͼ1000 nM). To confirm the specificity of the inhibitor, we next examined its effects on the activities of cathepsin L and cathepsin B in mouse liver ML fraction (Fig. 1) . There is no synthetic substrate that is specific for cathepsin L available. Hence we measured hydrolysis of z-Phe-Arg-MCA to quantify activity of both cathepsins BϩL and that of z-Arg-Arg-MCA to determine cathepsin B activity. z-Phe-Arg-MCA is cleaved by both cathepsin L and cathepsin B, whereas z-Arg-Arg-MCA is cleaved only by cathepsin B. As clearly shown in Fig. 1 , the activity of cathepsins BϩL was inhibited substantially by CA-074 and partially by CAA0225. CA-074 inhibited cathepsins BϩL activity by approximately 90%, while inhibition by CAA0225 was approximately 10% ( Fig. 1; upper   panel) . Inhibition of cathepsin B activity in liver ML fraction by CA-074 was nearly complete ( Fig. 1; middle panel) . In contrast, CAA0225 did not inhibit cathepsin B or cathepsin D ( Fig. 1 ; middle and bottom panels). These data are consistent with those obtained using purified cathepsin B and cathepsin L.
We next investigated the in vivo effects of the inhibitors on lysosomal protein degradation. HeLa and Huh-7 cells were cultured in DMEM/10% FCS containing 14 C-leucine for 22 h so as to label long-lived proteins. The cells were chased for 2 h with DMEM/10% FCS containing unlabeled 2 mM leucine then were incubated with HBSS-10 mM Hepes to induce autophagy by nutrient deprivation. Figure 2A summarizes the data for the degradation of long-lived proteins in HeLa cells. Autophagic proteolysis of long-lived proteins was inhibited significantly by E64d (approximately 3%), which is a general inhibitor of lyososmal cysteine proteinases. CA-074-Me, a membrane permeant form of CA-074, and CAA0225 inhibited autophagic protein degradation partially and moderately (approximately 2%). There were no significant differences in the magnitude of inhibition between CA-074-Me and CAA0225. Similarly, degradation of long-lived proteins of Huh-7 cells was partially inhibited by CA-074-Me and CAA0225 (Fig. 2B) . The data clearly show that the contributions of cathepsin L and cathepsin B to autophagic protein degradation are independent and nearly equal.
During starvation-induced autophagy in mammals, LC3-II is recruited to autophagosomal membranes, which engulf the cytoplasmic components to be degraded via autophagy. [16] [17] [18] [19] LC3-II is then degraded upon fusion of autophagosomes with lysosomes. 18, 19) It has been established that E64d, a general cysteine proteinase inhibitor, effectively inhibits degradation of LC3-II. Therefore during nutrient deprivation, accumulation of LC3-II in the presence of E64d is a convenient marker for autophagosomal turnover. [18] [19] [20] It is of interest to The activities of purified rat cathepsin L and cathepsin B were determined separately using z-Phe-Arg-MCA (cathepsin L) and z-Arg-Arg-MCA (cathepsin B) in the presence of various concentrations of the inhibitors, as described in Materials and Methods. Inhibition versus inhibitor concentration was plotted and the profile of activity plotted and IC 50 (nM) determined.
determine whether cathepsin L and cathepsin B contribute equally to LC3-II degradation.
When HeLa cells were incubated with HBSS-10 mM Hepes for 4 h, the band detected in immunoblots corresponding to LC3-II was faint ( Fig. 3; top panel) . In the presence of E64d, marked accumulation of LC3-II was detected ( Fig. 3 ; HeLa, E64d), indicating substantial activity of autophagic turnover in HeLa cells under these conditions. Intriguingly, LC3-II accumulated when the cells were treated with CAA0225, but not with CA-074. These results indicate that cathepsin L preferentially contributes to LC3-II turnover. In the case of Huh-7 cells, however, small amounts of LC3-II accumulated in the presence of E64d and CAA0225, and the inhibitor-dependent increase in LC3-II was less than that observed in HeLa cells ( Fig. 3; third panel) . We found that in Huh-7 cells, expression of GABARAP, which is another homologue of LC3 not expressed in HeLa cells, was significant. As clearly shown in Fig. 3 (fourth panel) , GABARAP-II, a membrane-bound form of GABARAP, accumulated markedly in the presence of E64d and CAA0225, but not in the presence of CA-074-Me. Thus autophagic turnover of GABARAP-II, another autophagosomal membrane marker, is strongly dependent on cathepsin L.
DISCUSSION
The results of the present study clearly indicate that CAA0225, a specific inhibitor of cathepsin L, can be used to assess the contribution of cathepsin L to lysosomal protein degradation. L-trans-epoxy-succinic acid group of E64c, a well-known inhibitor for cysteine proteinases including cathepsin B and cathepsin L, is critical for the inhibitor to bind to the active-site cysteine of these enzymes. In an earlier study, we systematically synthesized derivatives of E64c and developed a new L-trans-epoxysuccinyl peptide (CA-074), a specific inhibitor for cathepsin B.
3) We found that the npropylamide moiety of CA-074 is critical for specific inhibition of cathepsin B (Fig. 4; box) .
3) CAA0225 was also synthesized as one of these derivatives. Recently, a series of cathepsin L-specific inhibitors were developed and named the cathepsin L inhibitor Katunuma (CLIK) series. 8, 9) These inhibitors share the essential structure N-(trans-carbamoyloxyrane-2-carbonyl)-L-phenylalanine dimethylamide that is necessary for formation of a thioester bond with the active site of cathepsin L. Due to N-terminal pyridine part, the CLIK series of inhibitors do not fit into the active site of cathepsin B. 8) Instead, the C-terminal phenylalanine moiety of the CLIK series that is also present in CAA0225 is important for specific interaction with cathepsin L (Fig. 4 ; dotted box). 8) CAA0225 has a structural feature that is similar to the characteristic moiety of the CLIK series. The difference is that the phenylalanine dimethylamide moiety of the CLIK series is substituted with a phenylalanine phenyl-ethyl-amide moiety in CAA0225. It is likely that, because of this moiety, HeLa and Huh-7 cells cultured with DMEM/10% FCS were washed with PBS and incubated for 4 h with HBSS-10 mM Hepes-NaOH (pH 7.4) in the presence or absence of inhibitors (10 mg/ml). Then, the cells were harvested and solubilized with SDS-PAGE sample buffer. Solubilized samples (10 mg protein) were separated by SDS-PAGE using 12.5% SDS-polyacrylamide gels. Cellular levels of LC3-II and GABARAP-II as well as actin for normalization were detected by immunoblotting. Representative data of three different preparations are shown. The box shows the part of CA-074 necessary for specific interaction of CA-074 with cathepsin B, and the dotted box shows the moiety of CAA0225 important for specific interaction of CAA0225 with cathepsin L.
